Acute cholestatic hepatitis caused by amoxicillin/clavulanate
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | BERALDO, Daniel Oliveira | |
dc.contributor.author | MELO, Joanderson Fernandes | |
dc.contributor.author | BONFIM, Alexandre Vidal | |
dc.contributor.author | TEIXEIRA, Andrei Alkmim | |
dc.contributor.author | TEIXEIRA, Ricardo Alkmim | |
dc.contributor.author | DUARTE, Andre Loyola | |
dc.date.accessioned | 2014-04-25T22:04:56Z | |
dc.date.available | 2014-04-25T22:04:56Z | |
dc.date.issued | 2013 | |
dc.description.abstract | Amoxicillin/clavulanate is a synthetic penicillin that is currently commonly used, especially for the treatment of respiratory and cutaneous infections. In general, it is a well-tolerated oral antibiotic. However, amoxicillin/clavulanate can cause adverse effects, mainly cutaneous, gastrointestinal, hepatic and hematologic, in some cases. Presented here is a case report of a 63-year-old male patient who developed cholestatic hepatitis after recent use of amoxicillin/clavulanate. After 6 wk of prolonged use of the drug, he began to show signs of cholestatic icterus and developed severe hyperbilirubinemia (total bilirubin > 300 mg/L). Diagnostic investigation was conducted by ultrasonography of the upper abdomen, serum tests for infection history, laboratory screening of autoimmune diseases, nuclear magnetic resonance (NMR) of the abdomen with bile duct-NMR and transcutaneous liver biopsy guided by ultrasound. The duration of disease was approximately 4 mo, with complete resolution of symptoms and laboratory changes at the end of that time period. Specific treatment was not instituted, only a combination of anti-emetic (metoclopramide) and cholestyramine for pruritus. | |
dc.description.index | MEDLINE | |
dc.identifier.citation | WORLD JOURNAL OF GASTROENTEROLOGY, v.19, n.46, p.8789-8792, 2013 | |
dc.identifier.doi | 10.3748/wjg.v19.i46.8789 | |
dc.identifier.eissn | 2219-2840 | |
dc.identifier.issn | 1007-9327 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/5259 | |
dc.language.iso | eng | |
dc.publisher | BAISHIDENG PUBL GRP CO LTD | |
dc.relation.ispartof | World Journal of Gastroenterology | |
dc.rights | openAccess | |
dc.rights.holder | Copyright BAISHIDENG PUBL GRP CO LTD | |
dc.subject | Hepatology | |
dc.subject | Hepatitis | |
dc.subject | Amoxicillin/Clavulanate | |
dc.subject | Drug reactions | |
dc.subject | Hyperbilirubinemia | |
dc.subject.other | amoxicillin-clavulanic acid | |
dc.subject.other | drug-induced hepatitis | |
dc.subject.other | hepatotoxicity | |
dc.subject.other | association | |
dc.subject.wos | Gastroenterology & Hepatology | |
dc.title | Acute cholestatic hepatitis caused by amoxicillin/clavulanate | |
dc.type | article | |
dc.type.category | original article | |
dc.type.version | publishedVersion | |
dspace.entity.type | Publication | |
hcfmusp.author.external | BERALDO, Daniel Oliveira:Hosp Renascentista, Dept Internal Med, BR-37550000 Pouso Alegre, MG, Brazil; Univ Fed Sao Paulo, Escola Paulista Med, Dept Nephrol, BR-04023062 Sao Paulo, Brazil | |
hcfmusp.author.external | MELO, Joanderson Fernandes:Hosp Renascentista, Dept Internal Med, BR-37550000 Pouso Alegre, MG, Brazil | |
hcfmusp.author.external | BONFIM, Alexandre Vidal:Hosp Renascentista, Dept Internal Med, BR-37550000 Pouso Alegre, MG, Brazil; Univ Fed Sao Paulo, Escola Paulista Med, Dept Cardiol, BR-04023062 Sao Paulo, Brazil | |
hcfmusp.author.external | TEIXEIRA, Andrei Alkmim:Hosp Renascentista, Dept Internal Med, BR-37550000 Pouso Alegre, MG, Brazil; Univ Fed Sao Paulo, Escola Paulista Med, Dept Nephrol, BR-04023062 Sao Paulo, Brazil | |
hcfmusp.author.external | DUARTE, Andre Loyola:Hosp AC Camargo Fund Antonio Prudente, Dept Pathol, BR-01509010 Sao Paulo, Brazil | |
hcfmusp.citation.scopus | 11 | |
hcfmusp.contributor.author-fmusphc | RICARDO ALKMIM TEIXEIRA | |
hcfmusp.description.beginpage | 8789 | |
hcfmusp.description.endpage | 8792 | |
hcfmusp.description.issue | 46 | |
hcfmusp.description.volume | 19 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 24379601 | |
hcfmusp.origem.scopus | 2-s2.0-84890345398 | |
hcfmusp.origem.wos | WOS:000329129200039 | |
hcfmusp.publisher.city | WANCHAI | |
hcfmusp.publisher.country | PEOPLES R CHINA | |
hcfmusp.relation.reference | BENICHOU C, 1990, J HEPATOL, V11, P272 | |
hcfmusp.relation.reference | Brown SJ, 2002, SEMIN LIVER DIS, V22, P157, DOI 10.1055/s-2002-30103 | |
hcfmusp.relation.reference | Cundiff J, 2007, AM J OTOLARYNG, V28, P28, DOI 10.1016/j.amjoto.2006.06.007 | |
hcfmusp.relation.reference | Dandakis D, 2002, ANN GASTROENTOL H S1, V15, P85 | |
hcfmusp.relation.reference | Farrokhseresht R, 2001, SEMJ, V2, P53 | |
hcfmusp.relation.reference | Fontana RJ, 2005, DIGEST DIS SCI, V50, P1785, DOI 10.1007/s10620-005-2938-5 | |
hcfmusp.relation.reference | Hautekeete ML, 1999, GASTROENTEROLOGY, V117, P1181, DOI 10.1016/S0016-5085(99)70404-X | |
hcfmusp.relation.reference | HAUTEKEETE ML, 1995, J HEPATOL, V22, P71, DOI 10.1016/0168-8278(95)80262-2 | |
hcfmusp.relation.reference | Herrero-Herrero JI, 2010, J MED TOXICOL, V6, P420, DOI [10.1007/s13181-010-0019-4, DOI 10.1007/S13181-010-0019-4]] | |
hcfmusp.relation.reference | Kim Ju Seung, 2011, Korean J Hepatol, V17, P229, DOI 10.3350/kjhep.2011.17.3.229 | |
hcfmusp.relation.reference | Maria VAJ, 1997, HEPATOLOGY, V26, P664, DOI 10.1002/hep.510260319 | |
hcfmusp.relation.reference | RYLEY NG, 1995, J HEPATOL, V23, P278, DOI 10.1016/0168-8278(95)80471-4 | |
hcfmusp.relation.reference | Salvo F, 2007, J ANTIMICROB CHEMOTH, V60, P121, DOI 10.1093/jac/dkm111 | |
hcfmusp.relation.reference | Schey R, 2001, ANN PHARMACOTHER, V35, P1142 | |
hcfmusp.relation.reference | SILVAIN C, 1992, DIGEST DIS SCI, V37, P150, DOI 10.1007/BF01308359 | |
hcfmusp.relation.reference | Zaidi SA, 2003, AM J MED SCI, V325, P31, DOI 10.1097/00000441-200301000-00006 | |
hcfmusp.scopus.lastupdate | 2024-05-10 | |
relation.isAuthorOfPublication | a20d01a7-7bd0-42c5-bbaa-d3a6a072b7ab | |
relation.isAuthorOfPublication.latestForDiscovery | a20d01a7-7bd0-42c5-bbaa-d3a6a072b7ab |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- art_TEIXEIRA_Acute_cholestatic_hepatitis_caused_by_amoxicillin_clavulanate_2013.PDF
- Tamanho:
- 1.09 MB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)